| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.18B | +9.4% |
| R&D Expense | $1.67B | +13.8% |
| SG&A Expense | $1.62B | +24.6% |
| Operating Income | $1.44B | -37.8% |
| Pre-tax Income | $1.52B | -48.3% |
| Income Tax | $261.7M | -28.0% |
| Net Income | $1.26B | -51.1% |
| EPS (Basic) | $4.85 | -53.5% |
| EPS (Diluted) | $4.45 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.29B | +32.1% |
| Short-term Investments | $309.8M | — |
| Accounts Receivable | $307.1M | +15.8% |
| Current Assets | $20.39B | +12.6% |
| Total Assets | $29.67B | +31.6% |
| Current Liabilities | $8.70B | +9.6% |
| Long-term Debt | $7.21B | +70.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.43B | -5.1% |
| Investing Cash Flow | -$2.05B | -625.8% |
| Financing Cash Flow | $740.3M | -73.8% |
| -53.1% |
| Total Liabilities |
| $14.88B |
| +21.3% |
| Stockholders' Equity | $14.79B | +43.9% |